The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
4 v 1 on L2 next offer 5p but all gone quiet but I'm going to hold a while, I think it can get back to 6-10p range again for a nice short term profit
Thanks Chester, I'll get my yacht on order for delivery Q1 2030 in that case!
Hi Phil
From : PharmaWeb.com
'What is the market for exosome diagnostics and therapeutics?'
According to the report, the global exosome diagnostic and therapeutic industry was estimated at $224.34 million in 2020, and is anticipated to hit $2.9 billion by 2030, registering a CAGR of 29.4% from 2021 to 2030.
So it shows that there is definitely a growing market for a Fully Working Exosome Platform.
Chester.
Chester - the question I keep coming back to in my head is why the deals for exosomes appear to have dried up? There was a relative flurry of deals around 2018 to 2020, but nothing substantive since. Is it that exosomes aren't seen as a viable option for whatever reason (scalability, consistency etc)? Or is it that the first generation HEK derived exosomes (that the pre clinical deals were done on for codiak and evox etc) were found to have significant limitations?
If it's the former, then they may as well just pull the plug now. If it's the latter, then perhaps Rene is sitting on something huge that the industry has been waiting for. Proof will be in the pudding, and we will presumably find out one way or another in the next couple of months.
The attraction of this share is the potential upside if any positive news does land.
What we do know is that Exosomes have the potential to improve the targeted delivery of some drugs that lack the precision to find their designated human cells.
We also know that some fairly sizeable deals have already been made and Exosomes that achieve their potential will be worth £10M's.
Reneuron may have just proved that their Exosomes are some of the best in class.
Obviously proved in their own labs but interested parties must be examining the data.
My opinion is that they have better than a 50/50 chance to do a deal before next February/ March.
Added to these assumptions is that the market Capitalisation is so low that the Assets, Patents and Intellectual Property are probably worth much more.
Chester18.
I see that sell that you mentioned. Must have been a tight stop loss, otherwise why bother?
Might as well have given it a bit more room to run, if going to buy in the first place IMO, but to each their own.
5p quote for 250K shares. Almost 9p for a million. Obviously these things can change in either direction at the drop of a hat, but interesting nonetheless.
Come on, Iain, give us holders some early Xmas cheer :) GLA.
Mental, clear a seller, decent buys at 4.5p full offer and then one person who bought earlier sells again for no gain and people start selling way below the buying price, no wonder the mm's love it, they just hold out as long as they can and then they get rewarded with easy and decent profits
Blast back to 10p
I expect traders will be selling very soon for a small profit. Newbies left holding the baby here!
Sorry that was meant to be 4.175p to buy at first but as they worked the sell order they were happy to sell stock lower and lower and eventually 4p mid price to clear the last lot, nice profit for the mm at 3.85p, all those 100k buys at 4.125p the mm was making £275 profit each one
Either way we are going to go much higher tomorrow hopefully. There were no shares left at 4.25p just before close so expect a rally over 5p first thing
I am certainly not one of the more informed posters here, but in answer to your question: yes, potentially it could be of benefit to us and a number of similar outfits in this space.
Whether it actually gets off the ground is another matter. We can but hope :)
As to the matter of that big print today: it was clearly a seller. No way would a buy of that size, in a market cap that we currently have, with the small number of shares in issue, only see a 10% rise.
But hopefully that was the seller on fumes that I suggested was a possibility the other day.
We might enjoy a significant rise from here now, but I take nothing for granted.
Ultimately, I am only interested in hearing about a deal/deals that validate the investment case here - although do not get me wrong, I would gladly take an AIM special rapid multi-bag rise while we wait :) GLA.
With a single trade of almost 1.5 mill share s we should information on who traded in the morning.
It's good news you know, seller out price rises, buy order filled price drops.
1 million % a worked sell, look at the action it was 4.715p to buy then 4.125p then 4.1p then 4.04p then 4p mid price to buy and finally they cleared their order the price bounced back up to full offer at the close
That posted sell was almost certainly a buy hence the market went very strong and all the RSP reduced availability . In for a big rise I think here
Should probably say 13% up *at time of writing*. It'll no doubt find a way of finishing in the red, you would presume.
Not quite sure what to make of the 1.7m share 'sell'. Maybe it's a buy been worked for a few days at an average price above what was preceding? Would certainly seem odd if its a sell on the same day the price is up 13%. Curious action nonetheless.
Getting ready for takeoff on new finance deal
Note the huge sale worked at 3.85p, now the seller is out the mm's are moving up 2 of them on 4p bid now
Wonder if someone has had a heads uo
I have also been adding here. The reason is that the company are very happy with the data they have generated and are now in discussions with numerous third parties.
Not a suggestion that anyone should buy I might add, more an indication that there's a willing seller...
"noticed you could not buy 250k online"
250k readily on offer not long after...